Back
Acta Physiologica 2008; Volume 192, Supplement 661
Belgian Society for Fundamental and Clinical Physiology and Pharmacology, Spring Meeting 2007
4/21/2007-4/24/2007
University of Antwerp, Antwerp, Belgium
TRANSPLANTATION OF NEURAL PROGENITOR CELLS IN A SCLEROTIC HIPPOCAMPUS GIVE LONG TERM SURVIVAL AND DIFFERENTIATE MAINLY TOWARDS ASTROCYTES
Abstract number: O-05
Van Dycke1 A., Raedt1 R., Vonck1 K., Wadman2 W., Boon1 P.
1Laboratory for Clinical and Experimental Neurophysiology, Department of Neurology, Ghent University Hospital, Belgium
2Swammerdam Institute of Life Sciences, Department of Neurobiology, University of Amsterdam, The Netherlands.
Purpose: To evaluate survival, differentiation and migration of adult neural progenitor cells (aNPCs) after transplantation in a sclerotic hippocampus. Methods: aNPCs isolated from the subventricular zone (SVZ) of transgenic green fluorescent protein (GFP) mice were transplanted in intact and sclerotic hippocampi of respectively normal rats and rats with temporal lobe epilepsy after intrahippocampal injection of kainic acid (KA). aNPCs were transplanted 3 days and 3 weeks after KA injection. Rats were sacrificed 3 or 6 weeks after transplantation. Results: The total number of surviving GFP expressing cells 3 and 6 weeks after transplantation, was estimated to be ~1% of the number of transplanted cells in all groups. The survival rate was significantly higher when aNPCs were transplanted 3 days after KA injection compared to transplantation 3 weeks after KA injection. Migration of the cells was higher in intact hippocampi and did not change over time. The majority of the GFP positive cells expressed GFAP, a protein expressed by astrocytes. In the sclerotic hippocampi, there was a significantly higher differentiation towards astrocytes (50-70%) compared to non-sclerotic hippocampi (30-40%). Only a low percentage of cells differentiated towards neurons. Conclusions: We found that aNPCs isolated from SVZ survive long term as astrocyte-like cells in a sclerotic hippocampus. These results combined with the fact that aNPCs are an accessible, expandable, storable and multipotent cell source make that this cell type, engineered to secrete seizure-modifying substances, could be used for future cell therapy approaches to treat medically intractable seizures.
To cite this abstract, please use the following information:
Acta Physiologica 2008; Volume 192, Supplement 661 :O-05